Potential role of erythropoietin receptors and ligands in attenuating apoptosis and inflammation in critical limb ischemia
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine,Surgery
Reference38 articles.
1. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC);Dormandy;J Vasc Surg,2000
2. Therapeutic angiogenesis: a complex problem requiring a sophisticated approach;Webster;Cardiovasc Toxicol,2003
3. Functional ability in patients with critical limb ischaemia is unaffected by successful revascularisation;Cieri;Eur J Vasc Endovasc Surg,2011
4. The myopathy of peripheral arterial occlusive disease: part 1. Functional and histomorphological changes and evidence for mitochondrial dysfunction;Pipinos;Vasc Endovasc Surg,2007
5. The myopathy of peripheral arterial occlusive disease: part 2. Oxidative stress, neuropathy, and shift in muscle fiber type;Pipinos;Vasc Endovascular Surg,2008
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Angiogenic responses are enhanced by recombinant human erythropoietin in a model of periventricular white matter damage of neonatal rats through EPOR-ERK1 signaling;Journal of Neuropathology & Experimental Neurology;2024-01-23
2. Candesartan protects against unilateral peripheral limb ischemia in type-2 diabetic rats: Possible contribution of PI3K-Akt-eNOS-VEGF angiogenic signaling pathway;International Immunopharmacology;2023-03
3. Fasudil, a ROCK inhibitor, preserves limb integrity in a mouse model of unilateral critical limb ischemia: Possible interplay of inflammatory and angiogenic signaling pathways;Life Sciences;2022-11
4. Linking erythropoietin to Treg-dependent allograft survival through myeloid cells;JCI Insight;2022-05-23
5. Fasudil, A ROCK Inhibitor, Preserves Limb Integrity in a Mouse Model of Unilateral Critical Limb Ischemia: Possible Interplay of Inflammatory and Angiogenic Signaling Pathways;SSRN Electronic Journal;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3